1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6E1D83F416A83E5CF85256EAC006E28C5
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/setting-and-measuring-clear-goals-for-medical-programs?opendocument
18
19opendocument
2034.204.176.189
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Medical Affairs Medical Affairs Excellence

Setting and Measuring Clear Goals for Medical Programs

DB Image

ID: 4646


Features:

Graphics


Pages/Slides: 9


Published: Pre-2014


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Study Overview

Constant reevaluation and improvement is the key to a successful medical program. Program directors of pharmaceutical companies can benefit from this document by gaining a clear concept of the program at hand and its goals, detailing key factors such as whether the program supports overall strategy of the company and whether clear methods to achieving these goals are available. This nine-page document outlines devised proxy measures in the absence of direct measurement of ROI to measure program performance and identify value drivers.

Key Topics

  • Goal Setting
  • Shaping Perceptions of the Program
  • Measurement


Sample Best Practices
  • Establish clear activity goals to ensure that solid benefits are realized. At one studied benchmark partner, each specialist’s daily activities reflect the program's three overarching goals: communication, research, influence.
  • Conduct an early impact analysis to refine and promote the field-based medical system. Another studied company, for example, has conducted a review of the effectiveness of its field-based medical education program each year since the program’s launch.
  • Identify value drivers to make performance measurements more relevant and useful. One benchmark partner decided not to measure ROI at first, but to move toward hard numbers after two business cycles.

Methodology
The findings in this report are based on a Best Practices, LLC benchmarking project that researched the most effective and innovative practices of seven top pharmaceutical competitors.

Industries Profiled:
Pharmaceutical; Health Care; Biotech


Companies Profiled:
AstraZeneca; Sanofi-aventis; Merck; Schering-Plough; Pharmacia & Upjohn; GlaxoSmithKline; Pfizer

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.